{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T08:14:21Z","timestamp":1789546461737,"version":"build-2803163510"},"reference-count":21,"publisher":"BMJ","issue":"5","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2018,5]]},"abstract":"<jats:sec><jats:title>Aims<\/jats:title><jats:p>To evaluate the efficacy of a subconjunctival dexamethasone-releasing implant in preventing rejection of penetrating keratoplasty (PK) in an animal model.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Twenty-two rabbits underwent allogenic PK. After randomisation, they received either a 700\u2009\u00b5g dexamethasone implant under the conjunctiva at the end of surgery (n=10), one dexamethasone 1\u2009mg\/mL eye-drop thrice daily (n=6) or a placebo thrice daily (n=6). The suture was left in place. Animals were observed weekly by slit-lamp and optical coherence tomography with quantification of transparency, neovascularisation and central corneal thickness (CCT). At 5\u20136 weeks, they were euthanised for histology. The residual dexamethasone concentration in ocular tissues was measured with an ultra-performance liquid chromatography-tandem mass spectrometer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Placebo group: early neovascularisation was systematic, penetrating the graft by 270\u2013360\u00b0 at 5\u20136 weeks. Rejection occurred in 50% of cases. Eye-drop and implant groups: similar course without rejection at 6 weeks and normal CCT. Neovascularisation was observed in 5\/6 rabbits in the eye-drop group and in 6\/8 in the implant group, with two cases of new vessels penetrating the graft from week 3. Neovascularisation scores did not differ significantly between the two treatments and were significantly lower than for the placebo. Histology was in agreement in all cases. Implants disappeared after 3\u20135 weeks. No local side effect was observed. Tissue concentrations were all higher at day 8 (n=2) in the implant group than in the eye drop group and lower at 6 weeks (n=8).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In this PK model characterised by a high rejection rate, a subconjunctival dexamethasone implant was for 6 weeks as effective as the topical form in preventing allograft rejection.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bjophthalmol-2017-310734","type":"journal-article","created":{"date-parts":[[2018,2,3]],"date-time":"2018-02-03T17:20:19Z","timestamp":1517678419000},"page":"692-699","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Immunosuppression by a subconjunctival implant releasing dexamethasone in a rabbit model of penetrating keratoplasty"],"prefix":"10.1136","volume":"102","clinical-trial-number":[{"clinical-trial-number":"nct02834260","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Emmanuel","family":"Crouzet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaud","family":"Garcin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Gauthier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguo","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Perrache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Delavenne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Basset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Peoc\u2019h","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Gain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3486-2875","authenticated-orcid":false,"given":"Gilles","family":"Thuret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,2,3]]},"reference":[{"key":"2020050713011092000_102.5.692.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2007.04.008"},{"key":"2020050713011092000_102.5.692.2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.03-0536"},{"key":"2020050713011092000_102.5.692.3","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2008.140020"},{"key":"2020050713011092000_102.5.692.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2011.09.019"},{"key":"2020050713011092000_102.5.692.5","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/jamaophthalmol.2015.4776","article-title":"Global Survey of Corneal Transplantation and Eye Banking","volume":"134","author":"Gain","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"2020050713011092000_102.5.692.6","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/ICO.0000000000000403","article-title":"Prevention and treatment of corneal graft rejection: current practice patterns of the Cornea Society (2011)","volume":"34","author":"Kharod-Dholakia","year":"2015","journal-title":"Cornea"},{"key":"2020050713011092000_102.5.692.7","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.ophtha.2011.10.016","article-title":"Efficacy and safety of long-term corticosteroid eye drops after penetrating keratoplasty: a prospective, randomized, clinical trial","volume":"119","author":"Shimazaki","year":"2012","journal-title":"Ophthalmology"},{"key":"2020050713011092000_102.5.692.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2008.08.002"},{"key":"2020050713011092000_102.5.692.9","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1097\/ICO.0000000000000212","article-title":"Corneal graft rejection 10 years after penetrating keratoplasty in the cornea donor study","volume":"33","author":"Dunn","year":"2014","journal-title":"Cornea"},{"key":"2020050713011092000_102.5.692.10","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1038\/eye.2009.17","article-title":"Mechanisms of corneal allograft rejection and regional immunosuppression","volume":"23","author":"Coster","year":"2009","journal-title":"Eye"},{"key":"2020050713011092000_102.5.692.11","first-page":"CD007603","article-title":"Immunosuppressants for the prophylaxis of corneal graft rejection after penetrating keratoplasty","volume":"23","author":"Abudou","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2020050713011092000_102.5.692.12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1869-5760-3-7","article-title":"Subconjunctival dexamethasone implant for non-necrotizing scleritis","volume":"3","author":"Nascimento","year":"2013","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"2020050713011092000_102.5.692.13","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/ICO.0000000000000391","article-title":"Long-term resolution of immunological graft rejection after a dexamethasone intravitreal implant","volume":"34","author":"Vinciguerra","year":"2015","journal-title":"Cornea"},{"key":"2020050713011092000_102.5.692.14","first-page":"191","article-title":"An improved technique for experimental penetrating keratoplasty in rabbits","volume":"21","author":"Beyer","year":"1990","journal-title":"Ophthalmic Surg"},{"key":"2020050713011092000_102.5.692.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2010.01.015"},{"key":"2020050713011092000_102.5.692.16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000266814","article-title":"Topical dexamethasone lowers rabbit ocular tension, as does topical mifepristone (RU 486), a peripheral blocker of dexamethasone and progesterone","volume":"21","author":"Phillips","year":"1989","journal-title":"Ophthalmic Res"},{"key":"2020050713011092000_102.5.692.17","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.10-5285"},{"key":"2020050713011092000_102.5.692.18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.2007.00885.x"},{"key":"2020050713011092000_102.5.692.19","first-page":"339","article-title":"Studies on intraocular penetration and metabolism of fluometholone in rabbits: a comparison betwen dexamethasone and prednisolone acetate","volume":"19","author":"Yamauchi","year":"1975","journal-title":"Jap J Pharmacol"},{"key":"2020050713011092000_102.5.692.20","first-page":"63","article-title":"Ocular penetration of hydrocortisone and dexamethasone into the aqueous humour after subconjunctival injection","volume":"98","author":"Jain","year":"1978","journal-title":"Trans Ophthalmol Soc U K"},{"key":"2020050713011092000_102.5.692.21","doi-asserted-by":"publisher","DOI":"10.1016\/S0142-9612(02)00377-0"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2017-310734","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T08:55:46Z","timestamp":1601110546000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2017-310734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,3]]},"references-count":21,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,4,19]]},"published-print":{"date-parts":[[2018,5]]}},"alternative-id":["10.1136\/bjophthalmol-2017-310734"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2017-310734","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,3]]}}}